GlyTherix Ltd-preview

Glytherix

GlyTherix Ltd

Private

SydneyHealthcare & Life Scienceshttps://glytherix.com/

Last Round

Series B

Feb 16, 2024

Total Funding Raised

$2.14M

Momentum Score

50 /100

Company Overview

GlyTherix Ltd is a biotechnology company that develops a targeted radiotherapy platform designed to treat solid tumors by delivering antibody radiopharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

theranosticstargeted radiotherapyradioligand therapyantibody therapeuticsradiopharmaceuticalsGPC-1 targetsolid tumor therapyMiltuximabsee and treatlutetium-177zirconium-89cancer imagingPET imagingprostate cancer treatmentpancreatic cancer treatmentclinical-stage biotechantibody drug conjugatesADC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlyTherix Ltd Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GlyTherix Ltd Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Feb 16, 2024
Series A	Jul 22, 2023
Grant	Sep 8, 2022
Grant	Dec 1, 2021
Grant	Mar 3, 2021
Grant	Jul 16, 2020

View all Funding Rounds

GlyTherix Ltd Investors

Notable investors and investment history

Investor	Rounds
The University of Queensland	Grant
Australian Research Council	Grant
Therapeutic Innovation Australia	Grant
NSW Government	Grant
Australian Federal Government (Cooperative Research Centres Projects grant)	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 8, 2026
Monthly visitors increased 118% MoM, reaching 2K.
May 2, 2025
Monthly visitors increased 82% MoM, reaching 2K.

View all signals

GlyTherix Ltd Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GlyTherix Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GlyTherix Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney

Employee Range9

Year Founded2017

Last FundingFeb 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.